The diagnoses included IDH (Isocitrate DeHydrogenase) wild-type glioblastoma (GBM) (Patients 1 and 6), IDH mutant oligodendroglioma (Patient 2), IDH mutant astrocytoma (Patient 5), melanoma metastasis (Patient 4), and pituitary adenoma (Patient 3). Here, IDH3A is linked to oligodendroglioma.